• News
  • SAN DIEGO
  • Finance

DJO Finance reports Q4, 2013 net loss

DJO Global Inc., a provider of medical device solutions for musculoskeletal health, vascular health and pain management, announced financial results for its public reporting subsidiary, DJO Finance LLC, for the fourth quarter and fiscal year ended Dec. 31, 2013.

For the fourth quarter, DJOFL reported a net loss attributable to DJOFL of $131.8 million, compared to a net loss of $47.0 million for the fourth quarter of 2012. The increase in the net loss was due primarily to a year-end write-off of goodwill of $106.6 million, whereas the net loss for the fourth quarter of 2012 included a loss on modification and extinguishment of debt of $27.5 million.

For the 12 months ended Dec. 31, DJOFL reported a net loss of $203.5 million, compared to a net loss of $119.2 million for the 12 months of 2012.

Leave Your Comment

Comments are moderated by SDDT, in accordance with the SDDT Comment Policy, and may not appear on this commentary until they have been reviewed and deemed appropriate for posting. Also, due to the volume of comments we receive, not all comments will be posted.

SDDT Comment Policy: SDDT encourages you to add a comment to this discussion. You may not post any unlawful, threatening, defamatory, obscene, pornographic or other material that would violate the law. All comments should be relevant to the topic and remain respectful of other authors and commenters. You are solely responsible for your own comments, the consequences of posting those comments, and the consequences of any reliance by you on the comments of others. By submitting your comment, you hereby give SDDT the right, but not the obligation, to post, air, edit, exhibit, telecast, cablecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying and other information you provide via all forms of media now known or hereafter devised, worldwide, in perpetuity. SDDT Privacy Statement.

User Response
0 UserComments

Leave Your Comment

Comments are moderated by SDDT, in accordance with the SDDT Comment Policy, and may not appear on this commentary until they have been reviewed and deemed appropriate for posting. Also, due to the volume of comments we receive, not all comments will be posted.

SDDT Comment Policy: SDDT encourages you to add a comment to this discussion. You may not post any unlawful, threatening, defamatory, obscene, pornographic or other material that would violate the law. All comments should be relevant to the topic and remain respectful of other authors and commenters. You are solely responsible for your own comments, the consequences of posting those comments, and the consequences of any reliance by you on the comments of others. By submitting your comment, you hereby give SDDT the right, but not the obligation, to post, air, edit, exhibit, telecast, cablecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying and other information you provide via all forms of media now known or hereafter devised, worldwide, in perpetuity. SDDT Privacy Statement.